A. Chaturvedi

发表

Repurposing auranofin as an antifungal: In vitro activity against a variety of medically important fungi

Anand K. Ramasubramanian, A. Srinivasan, J. Lopez-Ribot, 2017, Virulence.

Treatment and prevention of Candida albicans biofilms with caspofungin in a novel central venous catheter murine model of candidiasis.

J. Lopez-Ribot, A. Lazzell, Priya Uppuluri, 2009, The Journal of antimicrobial chemotherapy.

A novel small molecule inhibitor of Candida albicans biofilm formation, filamentation and virulence with low potential for the development of resistance

J. Lopez-Ribot, S. Saville, A. Lazzell, 2015, npj Biofilms and Microbiomes.

Dispersion as an Important Step in the Candida albicans Biofilm Developmental Cycle

J. Köhler, A. Srinivasan, J. Lopez-Ribot, 2010, PLoS pathogens.

Monoclonal Immunoglobulin G1 Directed against Aspergillus fumigatus Cell Wall Glycoprotein Protects against Experimental Murine Aspergillosis

P. Shukla, A. K. Chaturvedi, S. Keshava, 2005, Clinical Diagnostic Laboratory Immunology.

Synthesis of galactopyranosyl amino alcohols as a new class of antitubercular and antifungal agents.

A. Gaikwad, P. Shukla, B. S. Srivastava, 2004, Bioorganic & medicinal chemistry letters.

Identification of a novel antifungal nonapeptide generated by combinatorial approach.

P. Shukla, Manish Kumar, B. Kundu, 2005, International journal of antimicrobial agents.

Use of a Genetically Engineered Strain To Evaluate the Pathogenic Potential of Yeast Cell and Filamentous Forms during Candida albicans Systemic Infection in Immunodeficient Mice

J. Lopez-Ribot, C. Monteagudo, S. Saville, 2007, Infection and Immunity.

Design, synthesis, and biological evaluation of 1,2,3-trisubstituted-1,4-dihydrobenzo[g]quinoxaline-5,10-diones and related compounds as antifungal and antibacterial agents.

P. Shukla, A. K. Chaturvedi, Hardesh K. Maurya, 2006, Bioorganic & medicinal chemistry.

Screening the medicine for malaria venture's Pandemic Response Box to identify novel inhibitors of Candida albicans and Candida auris biofilm formation.

H. Badali, J. Lopez-Ribot, F. Wormley, 2023, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Screening a Repurposing Library for Inhibitors of Multidrug-Resistant Candida auris Identifies Ebselen as a Repositionable Candidate for Antifungal Drug Development

J. Lopez-Ribot, F. Wormley, T. Patterson, 2018, Antimicrobial Agents and Chemotherapy.

Cryptococcus antigens and immune responses: implications for a vaccine

F. Wormley, A. K. Chaturvedi, A. Chaturvedi, 2013, Expert review of vaccines.

Development of Anti-Virulence Approaches for Candidiasis via a Novel Series of Small-Molecule Inhibitors of Candida albicans Filamentation

J. Lopez-Ribot, S. Saville, A. Lazzell, 2017, mBio.

New antifungal flavonoid glycoside from Vitex negundo.

P. Shukla, B. Sathiamoorthy, A. K. Chaturvedi, 2007, Bioorganic & medicinal chemistry letters.

Antifungal activity of marine sponge Haliclona exigua (Krikpatrick)

M. N. Srivastava, P. Shukla, S. Mishra, 2010 .

Efficacy of a Genetically Engineered Candida albicans tet-NRG1 Strain as an Experimental Live Attenuated Vaccine against Hematogenously Disseminated Candidiasis

J. Lopez-Ribot, C. Monteagudo, S. Saville, 2009, Clinical and Vaccine Immunology.

In Vitro Activity of Miltefosine against Candida albicans under Planktonic and Biofilm Growth Conditions and In Vivo Efficacy in a Murine Model of Oral Candidiasis

J. Lopez-Ribot, S. Rozental, A. K. Chaturvedi, 2015, Antimicrobial Agents and Chemotherapy.

High-Throughput Screening of the Repurposing Hub Library to Identify Drugs with Novel Inhibitory Activity against Candida albicans and Candida auris Biofilms

J. Lopez-Ribot, F. Wormley, T. Patterson, 2023, Journal of fungi.

Synthesis and biological evaluation of novel (L)-alpha-amino acid methyl ester, heteroalkyl, and aryl substituted 1,4-naphthoquinone derivatives as antifungal and antibacterial agents.

P. Shukla, A. K. Chaturvedi, V. K. Tandon, 2005, Bioorganic & medicinal chemistry letters.

Induction of Broad-Spectrum Protective Immunity against Disparate Cryptococcus Serotypes

Natalia Castro-Lopez, F. Wormley, A. K. Chaturvedi, 2017, Front. Immunol..

Vaccine-Mediated Immune Responses to Experimental Pulmonary Cryptococcus gattii Infection in Mice

S. Weintraub, J. Lopez-Ribot, F. Wormley, 2014, PloS one.

Antifungal activity in triterpene glycosides from the sea cucumber Actinopyga lecanora.

R. Kumar, P. Shukla, V. Lakshmi, 2007, Bioorganic & medicinal chemistry letters.

Synthesis of (1,4)-naphthoquinono-[3,2-c]-1H-pyrazoles and their (1,4)-naphthohydroquinone derivatives as antifungal, antibacterial, and anticancer agents.

P. Shukla, A. K. Chaturvedi, V. K. Tandon, 2005, Bioorganic & medicinal chemistry letters.

Physiologic Expression of the Candida albicans Pescadillo Homolog Is Required for Virulence in a Murine Model of Hematogenously Disseminated Candidiasis

Niketa M. Jani, J. Köhler, E. Mylonakis, 2012, Eukaryotic Cell.

Identification and characterization of Cryptococcus neoformans protein fractions that induce protective immune responses

S. Weintraub, J. Lopez-Ribot, F. Wormley, 2013, Proteomics.

Validation of the Tetracycline Regulatable Gene Expression System for the Study of the Pathogenesis of Infectious Disease

J. Lopez-Ribot, C. Monteagudo, F. Wormley, 2011, PloS one.

Characteristics of Candida albicans Biofilms Grown in a Synthetic Urine Medium

J. Lopez-Ribot, Priya Uppuluri, Hemamalini Dinakaran, 2009, Journal of Clinical Microbiology.

Design of a Simple Model of Candida albicans Biofilms Formed under Conditions of Flow: Development, Architecture, and Drug Resistance

J. Lopez-Ribot, Priya Uppuluri, A. K. Chaturvedi, 2009, Mycopathologia.

Development of an Imaging Flow Cytometry Method for Fungal Cytological Profiling and Its Potential Application in Antifungal Drug Development

J. Lopez-Ribot, F. Wormley, C. Hung, 2023, Journal of fungi.

A monoclonal IgM directed against immunodominant catalase B of cell wall of Aspergillus fumigatus exerts anti‐A. fumigatus activities

P. Shukla, Rohitash Kumar, Awanit Kumar, 2009, Mycoses.

Methodology for Anti-Cryptococcal Vaccine Development.

F. Wormley, A. K. Chaturvedi, A. Chaturvedi, 2017, Methods in molecular biology.

Synthesis and biological evaluation of novel 1,4-naphthoquinone derivatives as antibacterial and antiviral agents.

P. Shukla, A. K. Chaturvedi, V. K. Tandon, 2005, Bioorganic & medicinal chemistry letters.